These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15886297

  • 1. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S, Said JW, Popoviciu LM, Jones PA, Miyakawa I, Koeffler HP.
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 3. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W.
    Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180
    [Abstract] [Full Text] [Related]

  • 4. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
    Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R.
    Cancer Res; 2001 Jan 01; 61(1):97-102. PubMed ID: 11196205
    [Abstract] [Full Text] [Related]

  • 5. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O.
    Leuk Res; 2009 Mar 01; 33(3):443-9. PubMed ID: 18757096
    [Abstract] [Full Text] [Related]

  • 6. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R.
    Cancer Res; 2003 Jun 15; 63(12):3101-6. PubMed ID: 12810635
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y.
    J Pathol; 2007 Oct 15; 213(2):131-9. PubMed ID: 17724792
    [Abstract] [Full Text] [Related]

  • 8. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP.
    Cancer Res; 2006 Jun 01; 66(11):5582-91. PubMed ID: 16740693
    [Abstract] [Full Text] [Related]

  • 9. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 10. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
    Sasaki M, Kotcherguina L, Dharia A, Fujimoto S, Dahiya R.
    Cancer Res; 2001 Apr 15; 61(8):3262-6. PubMed ID: 11309276
    [Abstract] [Full Text] [Related]

  • 11. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Apr 15; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

  • 13. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
    Zhang J, Liu L, Pfeifer GP.
    Oncogene; 2004 Mar 18; 23(12):2241-9. PubMed ID: 14691453
    [Abstract] [Full Text] [Related]

  • 14. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
    Lopez-Serra L, Ballestar E, Ropero S, Setien F, Billard LM, Fraga MF, Lopez-Nieva P, Alaminos M, Guerrero D, Dante R, Esteller M.
    Oncogene; 2008 Jun 05; 27(25):3556-66. PubMed ID: 18223687
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H, Toyota M, Ishida W, Furihata M, Tsuchiya M, Kamada M, Tokino T, Shuin T.
    Oncogene; 2006 Mar 16; 25(12):1733-42. PubMed ID: 16278676
    [Abstract] [Full Text] [Related]

  • 16. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C.
    Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391
    [Abstract] [Full Text] [Related]

  • 17. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 15; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 18. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
    Oncogene; 2005 Nov 24; 24(53):7946-52. PubMed ID: 16007117
    [Abstract] [Full Text] [Related]

  • 19. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C.
    Oncogene; 2009 Jul 02; 28(26):2466-75. PubMed ID: 19448674
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS.
    Cancer Res; 2005 Sep 01; 65(17):7763-74. PubMed ID: 16140944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.